Detailed description of the main functions and applicable groups of eflornithine (IWILFIN)

Eflornithine (IWILFIN) is an anti-metabolite drug that mainly exerts anti-cancer effects by inhibiting DNA synthesis and RNA transcription in tumor cells. Its mechanism of action is similar to other pyrimidine analogs, inhibiting tumor growth and spread by blocking key metabolic pathways required for tumor cell proliferation. Eflornithine has shown certain efficacy on a variety of solid tumors and some hematological tumors, and is one of the clinically important chemotherapy options.

Eflornithine is mainly used to treat patients with solid tumors that do not respond well to conventional chemotherapy drugs, such as colorectal cancer, gastric cancer, and certain types of lung cancer. Its anti-tumor activity is closely related to the patient's metabolic capacity and tumor cell proliferation rate. Therefore, during use, individualized dosage adjustment is required based on the patient's pathological type, stage and physical condition to ensure maximum efficacy and reduce the risk of adverse reactions.

In clinical application, eflornithine can be used as a single agent or in combination with other chemotherapy drugs to enhance the anti-tumor effect. For example, in combination treatment regimens, it is often used in conjunction with drugs such as oxaliplatin and cisplatin to improve tumor response rates and survival benefits through multi-mechanical synergy. When used together, hematological indicators and liver and kidney functions need to be closely monitored to prevent cumulative drug toxicity.

The applicable population is mainly adult tumor patients, especially those who are resistant to or relapsed with other conventional chemotherapy regimens. During use, the dosage needs to be adjusted according to the patient's age, liver and kidney function, and previous medication history, and hematological and biochemical indicators must be monitored regularly. For patients who are frail or have severe diseases, they should be used with caution under the guidance of a professional doctor to ensure safety and therapeutic effect.

Reference materials:https://www.drugs.com/